147 / 374
147
Simposium
Bibliografía
1. Ibáñez MD, Garde JM. Allergy in pata-
llergy ients under fourteen tears of age
in Alergológica 2005. J Investig Aller-
gol Clin Immunoj l. 2009;19:61-68.
2. Dykewicz M. Rhinitis and sinusitis. J
Allergy Clin Immunol 2003;111:S520-
529.
3. WH. Donshik PC. Allergic ocular
disorders:a spectrum of diseases. Clao
J.,1992.18(2):117-124.
4. Worlwide variation in prevalence of
symptoms of asthma, allergic rhino-
conjuintivitis, and atopic eczema: ISA-
AC.The international Study of asthma
and Allergies in childhood (ISAAC)
Steering Committee. Lancet. 1998;
351:1125-32.
5. Alergia en menores de 14 años. En:
Sociedad Española de Alergología
e inmunologia Clínica. Alergológica
2005. Factores epidemiológicos, clíni-
cos y socioeconómicos de las enfer-
medades alérgicas en España. Madrid
2006. p325-383.
6. Kuling M, Klettle U, Wahn V, Forster
J, Bauer CP, Wahn U. Development of
seasonal llergic rhinitis during the first
7 years of life. J Allergy Clin Immunol
2000;106:832-9.
7. Bousquet J, Van Cauwenberge P, Khal-
taev N in collaboration with the World
Health Organization. Allergic Rhinitis
and its Impact on Asthma. J Allergy Clin
Immunol 2001; 108(5 supl):147S-333S.
8. Bonini S, Lambiase A, Magrini L, Rumi
C, Del Prete G, Schiavone M, Rotiroti
G, Onorati P, Rutella S. Vernal kerato-
conjunctivitis: a model of 5q cytokine
gene cluster disease. Int Arch Allergy
Immunol.,1995;107:1-3.
9. Moller C et al. Pollen immunotherapy
reduces the development of asthma in
children with seasonal rhinoconjuncti-
vitis (the PAT-study). J Allergy Clin Im-
munol 2002;109(2): 251-6
10. Niggemann B. et al. Five-year follow
up on the PAT study: specific immu-
notherapy and long term prevention
of asthma in children. Allergy 2006; Jul
61(7): 855-9.
11. Derendorf H, Munzel U, Petzold U,
Maus J, Mascher H, Hermann R, Bous-
quet J. Bioavailability and disposition
ofazelastine and fluticasone propiona-
te when delivered by MP29-02, a novel
aqueous nasal spray. Br J clin Pharma-
col 2012, 74(1):125-33
12. CarrW, Bernstein J, Lieberman P, Melt-
zer E, Bachert C, Price D, Munzel U,
Bousquet J. A novel intranasal therapy
of azelastine with fluticasone for the
treatment of allergic rinitis. J Allerg
Clin Immunol 2012;129:1282-9.
13. Meltzer E, Ratner P, Bachert C, Carr
W, Berger W, Canonica GW, Hadley
J et al. Clinically relevant effect of a
new intranasal therapy (MP29-02) in